Cascade Chemistry begins $14m manufacturing facility expansion
February 19, 2021Medical Communications Cascade Chemistry, manufacturing
Cascade Chemistry, a leading pharmaceutical contract development and manufacturing organisation, has initiated the $14 million construction of new facilities to …
Dermavant announces positive Phase III findings for psoriasis treatment tapinarof
February 19, 2021Medical Communications Dermavant Sciences, psoriasis
Dermavant Sciences has announced positive safety and efficacy results from a planned interim analysis of PSOARING 3, a long-term, open-label …
RedHill enters manufacturing deal with Cosmo for two key products
February 19, 2021Medical Communications RedHill Biopharma
RedHill Biopharma has announced agreements with Cosmo Pharmaceuticals to manufacture two of RedHill’s key products. Cosmo will manufacture Movantik, RedHill’s …
Onward and Biomunex agree deal to collaborate on cancer treatment
February 18, 2021Onward Therapeutics and Biomunex Pharmaceuticals have signed a co-development agreement of a bi-specific antibody for cancer patients.
Nektar and SFJ collaborate to develop experimental head and neck cancer drug
February 18, 2021Cancer, Nektar Therapeutics
Nektar Therapeutics has announced a financing and co-development collaboration with SFJ Pharmaceuticals to support the development of Bempegaldesleukin (BEMPEG), an investigational CD122-preferential …
MC2 Therapeutics grants Almirall European commercial rights for psoriasis cream Wynzora
February 18, 2021Almirall, MC2 Therapeutics, psoriasis
Biopharma company Almirall and MC2 Therapeutics, a pharmaceutical company focused on therapies for autoimmune and chronic inflammatory conditions, have announced …
Eli Lilly’s diabetes drug tirzepatide reduces blood glucose and weight in Phase III trials
February 18, 2021Eli Lilly, diabetes
Eli Lilly’s tirzepatide led to significant haemoglobin A1C (HbA1C) and body weight reductions from baseline in adults with type 2 …
Pharmafile.com’s weekly COVID-19 news round-up
February 17, 2021Research and Development COVID-19, COVID-19 vaccine, Vaccine, World Health Organisation, covid-19 roundup
The past week has continued to see positive COVID-19 vaccine news; a WHO panel approved the Oxford-AstraZeneca vaccine for all …
J&J’s one-shot COVID-19 vaccine submitted to the EU
February 17, 2021Research and Development COVID, COVID Vaccine, COVID-19, Johnson & Johnson, Vaccine
Johnson & Johnson has applied to the EMA for marketing authorisation of their one-shot COVID-19 vaccine in Europe.
AstraZeneca and MSD’s Lynparza crosses superiority boundary for invasive disease-free survival
February 17, 2021Research and Development AstraZeneca, Cancer, MSD
The OlympiA Phase III trial for AstraZeneca and MSD’s cancer drug Lynparza will move to early primary analysis and reporting, …
Novartis and Gates Foundation join forces on sickle cell disease research
February 17, 2021Research and Development Novartis, sickle cell disease
Novartis has entered into a grant agreement with the Bill & Melinda Gates Foundation, under which the foundation will fund …
FDA approves Novartis’ heart failure drug Entresto
February 17, 2021Research and Development FDA, Novartis
The FDA has approved Novartis’ Entresto (sacubitril/valsartan) to reduce the risk of cardiovascular death and hospitalisation for heart failure in …
North Korea accused of attempted Pfizer hack to steal COVID-19 vaccine data
February 16, 2021Manufacturing and Production COVID, COVID Vaccine, COVID-19, North Korea, Pfizer, Pfizer vaccine, Vaccine
North Korea has tried to hack into Pfizer’s servers in order to ascertain its COVID-19 vaccine technology, according to a …
South Korea orders 46 million more Novavax and Pfizer COVID-19 vaccines
February 16, 2021Manufacturing and Production COVID, COVID-19, Novavax, Pfizer, Vaccine, south korea
South Korea has arranged deals with Novavax and Pfizer-BioNTech to buy enough COVID-19 vaccines for 23 million more people.
WHO approves two versions of AstraZeneca’s COVID-19 vaccine
February 16, 2021Manufacturing and Production AstraZeneca, COVID-19, WHO
The WHO has greenlighted two versions of the Oxford-AstraZeneca COVID-19 vaccine for emergency use, granting them authorisation to be rolled …
Daiichi Sankyo and AstraZeneca’s breast cancer drug Enhertu approved in UK
February 16, 2021Manufacturing and Production AstraZeneca, Cancer, Daiichi Sankyo
Daiichi Sankyo and AstraZeneca’s Enhertu (trastuzumab deruxtecan) has been granted conditional authorisation in the UK as a monotherapy for the …
Celltrion’s inflammatory disease drug Yuflyma gets EU approval for 13 indications
February 16, 2021Manufacturing and Production EC, celltrion
The European Commission (EC) has granted marketing authorisation for Celltrion’s Yuflyma, an adalimumab biosimilar, across all thirteen intended indications for …
University of Glasgow and Lilly sign £4.6m immunological disease partnership
February 15, 2021Sales and Marketing Eli Lilly, University of Glasgow, arthritis, fibrosis, lilly, uofg
The University of Glasgow and Eli Lilly and Company have entered into a research collaboration, across four diseases, worth £4.6 …
Pfizer COVID-19 vaccine proven 94% effective in biggest study yet
February 15, 2021Sales and Marketing COVID-19, Pfizer, Pfizer vaccine, Vaccine, coronavirus
The Pfizer-BioNTech COVID-19 vaccine has been proven to be 94% effective, according to the first major study to evaluate the …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
